Fight Colorectal Cancer (Fight CRC) and healthcare technology firm Flatiron Health have developed and launched a mobile application of Late-Stage, MSS-CRC Clinical Trial Finder.
The app, available for both Android and iOS users, is designed to help late-stage microsatellite stable (MSS) colorectal cancer patients search for appropriate clinical trials using their smartphone.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
A web-version of the Clinical Trial Finder was created by the partners in 2017. The solution builds on the work of scientist and stage IV colorectal cancer survivor Dr Tom Marsilje.
Originally, Marsilje curated a list of MSS-CRC clinical trials in a spreadsheet, which was then further developed by Flatiron Health and Fight CRC.
Fight CRC noted that approximately 14,000 people have used the tool for a total of more than 24,000 unique searches since May 2017.
Fight CRC president Anjee Davis said: “The launch of this app for the Fight CRC Clinical Trial Finder is what Tom always envisioned. It will be a game changer for patients and caregivers–delivering the latest in clinical trials to their phones and giving them a sense of control during a time when they so often feel powerless.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe Clinical Trial Finder provides a curated list of potential, enrolling trials for MSS-CRC patients.
It is updated daily based on a publicly available repository available on ClinicalTrials.gov maintained by the Clinical Trials Transformation Initiative (CTTI).
Patients and their caregivers will be able to find suitable trials to discuss with their medical team.
Flatiron Health Research Oncology vice-president Neal Meropol said: “Empowering patients and improving access to clinical trials will help us continue to move the needle for patients with colorectal cancer.”
